BioSpace News Archive

Business

Satellos Bioscience Co-Founder and Chief Scientific Officer Dr. Michael Rudnicki Published in Nature Communications

The article, titled “GLI3 regulates muscle stem cell entry into GAlert and self-renewal”, looks at the critical role that GLI3 plays in satellite cell formation and new findings on its potential to regulate muscle stem cell activation and fate.

July 13, 2022
·
5 min read
Drug Development

Fulcrum Phase 3 FSHD Clinical Trial using AMRA Medical’s Whole-body MRI Measurements as a Key Secondary Endpoint

REACH, a Phase 3 Clinical Trial of losmapimod in Facioscapulohumeral Muscular Dystrophy (FSHD) utilizes AMRA’s Muscle Fat Infiltration (MFI) as a secondary endpoint.

July 13, 2022
·
3 min read
SoniVie Announces successful procedure with TIVUS system on first patient enrolled for REDUCED1 Pilot study

SoniVie announced that on May 30th 2022 the first patient was treated with its Renal Artery Denervation TIVUS™ technology, as part of the recently FDA IDE-approved Pilot study to treat Hypertension.

July 13, 2022
·
2 min read
Opioid Pain Therapeutics Market: Technological Advancement and New Product Lunch to Drive the Market

Wilmington, Delaware, United States, Transparency Market Research Inc.: Potent pain reducing medications made with compounds such as morphine, hydrocodone, codeine, methadone, and oxycodone fall under the category of opioid drugs.

July 13, 2022
·
8 min read
Business

XVIVO Presents Interim Report January-June 2022

Net sales amounted to SEK 94.3 million (59.3), corresponding to an increase of 59 percent in SEK and 44 percent in local currencies.

July 13, 2022
·
5 min read
Philips highlights AI-powered precision diagnosis portfolio at ECR 2022

Royal Philips, a global leader in health technology, will showcase its award-winning AI-powered systems and solutions debuting at the European Congress of Radiology.

July 13, 2022
·
9 min read
InDex Pharmaceuticals gets new patent for cobitolimod granted in Europe

InDex Pharmaceuticals Holding AB announced that a new method of use patent for the drug candidate cobitolimod has been granted by the European Patent Office.

July 13, 2022
·
2 min read
Drug Development

Pluristem Reports Topline Results from its Phase III Study of Muscle Regeneration Following Hip Fracture Surgery

Pluristem Therapeutics Inc., a leading biotechnology company, announced topline results from its multinational double-blind, placebo-controlled phase III study.

July 13, 2022
·
8 min read
Drug Development

Nuvalent to Present New NVL-655 Preclinical Data and ARROS-1 Trial in Progress Poster for NVL-520 at IASLC 2022 World Conference on Lung Cancer Annual Meeting

Nuvalent, Inc. announced it will present two posters for its parallel lead programs, NVL-655, an ALK-selective inhibitor and NVL-520, a ROS1-selective inhibitor, at the IASLC 2022 World Conference on Lung Cancer Annual Meeting taking place August 6-9, 2022 in Vienna, Austria.

July 13, 2022
·
8 min read
Business

Merck and Orion Announce Global Collaboration for the Development and Commercialization of ODM-208, an Investigational Steroid Synthesis Inhibitor for the Treatment of Metastatic Castration-Resistant Prostate Cancer

Merck, known as MSD outside the United States and Canada, and Orion Corporation announced a global development and commercialization agreement for Orion’s investigational candidate ODM-208 and other drugs targeting cytochrome P450 11A1, an enzyme important in steroid production.

July 13, 2022
·
6 min read